{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:37:57Z","timestamp":1787074677491,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH-NIAMS","award":["R01AR078230"],"award-info":[{"award-number":["R01AR078230"]}]},{"name":"NIH-NIAMS","award":["R21AR084644"],"award-info":[{"award-number":["R21AR084644"]}]},{"name":"NIH-NIAMS","award":["R01AR086572"],"award-info":[{"award-number":["R01AR086572"]}]},{"name":"NIH","award":["P30AR075042"],"award-info":[{"award-number":["P30AR075042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-06012-0","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T15:34:51Z","timestamp":1768491291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["USP8-mediated mitochondrial regulation in osteoclasts is essential for skeletal development"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-2034","authenticated-orcid":false,"given":"Sachin","family":"Chaugule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Suk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-3293","authenticated-orcid":false,"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"1","key":"6012_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann N Y Acad Sci 1092(1):385\u2013396","journal-title":"Ann N Y Acad Sci"},{"key":"6012_CR2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.95083","volume":"13","author":"V Daponte","year":"2024","unstructured":"Daponte V, Henke K, Drissi H (2024) Current perspectives on the multiple roles of osteoclasts: mechanisms of osteoclast\u2013osteoblast communication and potential clinical implications. Elife 13:e95083","journal-title":"Elife"},{"issue":"21","key":"6012_CR3","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/cells12212576","volume":"12","author":"V \u0160romov\u00e1","year":"2023","unstructured":"\u0160romov\u00e1 V, Sobola D, Kaspar P (2023) A brief review of bone cell function and importance. Cells 12(21):2576","journal-title":"Cells"},{"issue":"12","key":"6012_CR4","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.3390\/biomedicines12122662","volume":"12","author":"F Hern\u00e1ndez-Garc\u00eda","year":"2024","unstructured":"Hern\u00e1ndez-Garc\u00eda F et al (2024) The crosstalk between cartilage and bone in skeletal growth. Biomedicines 12(12):2662","journal-title":"Biomedicines"},{"issue":"6","key":"6012_CR5","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1083\/jcb.201902074","volume":"218","author":"L Song","year":"2019","unstructured":"Song L, Luo Z-Q (2019) Post-translational regulation of ubiquitin signaling. J Cell Biol 218(6):1776\u20131786","journal-title":"J Cell Biol"},{"key":"6012_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041526","author":"J Qu","year":"2021","unstructured":"Qu J, Zou T, Lin Z (2021) The roles of the Ubiquitin-Proteasome System in the endoplasmic reticulum stress pathway. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22041526","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6012_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague MJ, Urb\u00e9 S, Komander D (2019) Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol 20(6):338\u2013352","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"6012_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/iub.300","volume":"62","author":"JJ Sacco","year":"2010","unstructured":"Sacco JJ et al (2010) Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life 62(2):140\u2013157","journal-title":"IUBMB Life"},{"issue":"12","key":"6012_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tcb.2004.10.006","volume":"14","author":"CA Ross","year":"2004","unstructured":"Ross CA, Pickart CM (2004) The ubiquitin-proteasome pathway in Parkinson\u2019s disease and other neurodegenerative diseases. Trends Cell Biol 14(12):703\u2013711","journal-title":"Trends Cell Biol"},{"key":"6012_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101088","volume":"61","author":"K-H Lim","year":"2020","unstructured":"Lim K-H, Joo J-Y, Baek K-H (2020) The potential roles of deubiquitinating enzymes in brain diseases. Ageing Res Rev 61:101088","journal-title":"Ageing Res Rev"},{"issue":"1","key":"6012_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA et al (2018) Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov 17(1):57\u201378","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"6012_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.4015","volume":"35","author":"Q Li","year":"2020","unstructured":"Li Q et al (2020) Ubiquitin-specific protease 34 inhibits osteoclast differentiation by regulating NF-\u03baB signaling. J Bone Miner Res 35(8):1597\u20131608","journal-title":"J Bone Miner Res"},{"issue":"5","key":"6012_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/jcp.30990","volume":"238","author":"Y Cao","year":"2023","unstructured":"Cao Y et al (2023) CYLD inhibits osteoclastogenesis to ameliorate alveolar bone loss in mice with periodontitis. J Cell Physiol 238(5):1036\u20131045","journal-title":"J Cell Physiol"},{"issue":"12","key":"6012_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255233","volume":"23","author":"A Martens","year":"2022","unstructured":"Martens A et al (2022) A20 controls RANK-dependent osteoclast formation and bone physiology. EMBO Rep 23(12):e55233","journal-title":"EMBO Rep"},{"key":"6012_CR15","doi-asserted-by":"publisher","DOI":"10.1242\/dev.199908","author":"Y Yahara","year":"2022","unstructured":"Yahara Y et al (2022) The origins and roles of osteoclasts in bone development, homeostasis and repair. Development. https:\/\/doi.org\/10.1242\/dev.199908","journal-title":"Development"},{"key":"6012_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-pathmechdis-031521-040919","volume":"18","author":"DJ Veis","year":"2023","unstructured":"Veis DJ, Brien CA (2023) Osteoclasts, master sculptors of bone. Annu Rev Pathol Mech Dis 18:257\u2013281","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"4","key":"6012_CR17","doi-asserted-by":"publisher","first-page":"e70159","DOI":"10.1002\/mco2.70159","volume":"6","author":"Y Lin","year":"2025","unstructured":"Lin Y et al (2025) Posttranslational modification in bone homeostasis and osteoporosis. MedComm 6(4):e70159","journal-title":"MedComm"},{"key":"6012_CR18","doi-asserted-by":"publisher","first-page":"1033223","DOI":"10.3389\/fcell.2022.1033223","volume":"21","author":"Y Pan","year":"2022","unstructured":"Pan Y et al (2022) Ubiquitin modification in osteogenic differentiation and bone formation: From mechanisms to clinical significance. Front Cell Dev Biol 21:1033223","journal-title":"Front Cell Dev Biol"},{"issue":"48","key":"6012_CR19","doi-asserted-by":"publisher","first-page":"37895","DOI":"10.1074\/jbc.M110.129411","volume":"285","author":"I Berlin","year":"2010","unstructured":"Berlin I et al (2010) The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome. J Biol Chem 285(48):37895\u201337908","journal-title":"J Biol Chem"},{"issue":"13","key":"6012_CR20","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1128\/MCB.01566-06","volume":"27","author":"S Niendorf","year":"2007","unstructured":"Niendorf S et al (2007) Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol Cell Biol 27(13):5029\u20135039","journal-title":"Mol Cell Biol"},{"key":"6012_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910289","author":"S Chaugule","year":"2021","unstructured":"Chaugule S et al (2021) Deubiquitinating enzyme USP8 is essential for skeletogenesis by regulating Wnt signaling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221910289","journal-title":"Int J Mol Sci"},{"issue":"9","key":"6012_CR22","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni.3230","volume":"16","author":"A Dufner","year":"2015","unstructured":"Dufner A et al (2015) The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells. Nat Immunol 16(9):950\u2013960","journal-title":"Nat Immunol"},{"issue":"1","key":"6012_CR23","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","volume":"10","author":"YS Yang","year":"2019","unstructured":"Yang YS et al (2019) Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun 10(1):2958","journal-title":"Nat Commun"},{"issue":"1","key":"6012_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW et al (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 28(1):2\u201317","journal-title":"J Bone Miner Res"},{"issue":"6","key":"6012_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM et al (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2(6):595\u2013610","journal-title":"J Bone Miner Res"},{"issue":"12","key":"6012_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):1\u201321","journal-title":"Genome Biol"},{"issue":"43","key":"6012_CR27","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6012_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/cpmo.21","volume":"7","author":"PM Quiros","year":"2017","unstructured":"Quiros PM et al (2017) Analysis of mtDNA\/nDNA ratio in mice. Curr Protoc Mouse Biol 7(1):47\u201354","journal-title":"Curr Protoc Mouse Biol"},{"key":"6012_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bav006","author":"F Belinky","year":"2015","unstructured":"Belinky F et al (2015) Pathcards: multi-source consolidation of human biological pathways. Database. https:\/\/doi.org\/10.1093\/database\/bav006","journal-title":"Database"},{"issue":"2","key":"6012_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.chembiol.2023.01.001","volume":"30","author":"T Janiszewski","year":"2023","unstructured":"Janiszewski T et al (2023) Investigation of osteoclast cathepsin K activity in osteoclastogenesis and bone loss using a set of chemical reagents. Cell Chem Biol 30(2):159-174.e8","journal-title":"Cell Chem Biol"},{"issue":"2","key":"6012_CR31","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15548627.2015.1009794","volume":"11","author":"TM Durcan","year":"2015","unstructured":"Durcan TM, Fon EA (2015) USP8 and PARK2\/parkin-mediated mitophagy. Autophagy 11(2):428\u2013429","journal-title":"Autophagy"},{"key":"6012_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117505","volume":"181","author":"L Pei","year":"2024","unstructured":"Pei L et al (2024) Mitochondria in skeletal system-related diseases. Biomed Pharmacother 181:117505","journal-title":"Biomed Pharmacother"},{"key":"6012_CR33","doi-asserted-by":"publisher","first-page":"675385","DOI":"10.3389\/fendo.2021.675385","volume":"12","author":"W Da","year":"2021","unstructured":"Da W, Tao L, Zhu Y (2021) The role of osteoclast energy metabolism in the occurrence and development of osteoporosis. Front Endocrinol 12:675385","journal-title":"Front Endocrinol"},{"issue":"1","key":"6012_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi G, Schwarz T (2013) The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20(1):31\u201342","journal-title":"Cell Death Differ"},{"issue":"8","key":"6012_CR35","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/cells12081143","volume":"12","author":"S Mauri","year":"2023","unstructured":"Mauri S et al (2023) Usp8 down-regulation promotes Parkin-independent mitophagy in the Drosophila brain and in human neurons. Cells 12(8):1143","journal-title":"Cells"},{"key":"6012_CR36","doi-asserted-by":"crossref","unstructured":"S\u00f6derstr\u00f6m M et al. (1999) Cathepsin expression during skeletal development1The following nucleotide sequence data reported in this paper have been submitted to the EMBL Nucleotide Sequence Database: human cathepsin B (accession No. Y18460), human cathepsin H (Y18461), human cathepsin L (Y18462), mouse cathepsin B (Y18463), mouse cathepsin H (Y18464), mouse cathepsin L (Y18465) and mouse cathepsin S (Y18466).1. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1446(1):35\u201346","DOI":"10.1016\/S0167-4781(99)00068-8"},{"issue":"7","key":"6012_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26072896","volume":"26","author":"L Brizuela","year":"2025","unstructured":"Brizuela L et al (2025) Cathepsin K inhibitors as potential drugs for the treatment of osteoarthritis. Int J Mol Sci 26(7):2896","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6012_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41413-018-0019-6","volume":"6","author":"Y Han","year":"2018","unstructured":"Han Y et al (2018) Paracrine and endocrine actions of bone\u2014the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res 6(1):16","journal-title":"Bone Res"},{"issue":"4","key":"6012_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0002-9440(10)63368-8","volume":"165","author":"YE Chen","year":"2004","unstructured":"Chen YE (2004) MMP-12, an old enzyme plays a new role in the pathogenesis of rheumatoid arthritis? Am J Pathol 165(4):1069\u20131070","journal-title":"Am J Pathol"},{"issue":"33","key":"6012_CR40","doi-asserted-by":"publisher","first-page":"11917","DOI":"10.1073\/pnas.0502188102","volume":"102","author":"LFL Coelho","year":"2005","unstructured":"Coelho LFL et al (2005) Interferon-\u03b1 and -\u03b2 differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc Natl Acad Sci U S A 102(33):11917\u201311922","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6012_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/imm.12560","volume":"147","author":"AA Dar","year":"2016","unstructured":"Dar AA et al (2016) Extracellular 2\u20195\u2019-oligoadenylate synthetase 2 mediates T-cell receptor CD3-\u03b6 chain down-regulation via caspase-3 activation in oral cancer. Immunology 147(2):251\u2013264","journal-title":"Immunology"},{"issue":"4","key":"6012_CR42","doi-asserted-by":"publisher","first-page":"C673","DOI":"10.1152\/ajpcell.00331.2015","volume":"311","author":"QQ Huang","year":"2016","unstructured":"Huang QQ et al (2016) Deletion of calponin 2 in macrophages attenuates the severity of inflammatory arthritis in mice. Am J Physiol Cell Physiol 311(4):C673-c685","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"6012_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00198-007-0517-7","volume":"19","author":"BH Mullin","year":"2008","unstructured":"Mullin BH et al (2008) Bone structural effects of variation in the TNFRSF1B gene encoding the tumor necrosis factor receptor 2. Osteoporos Int 19(7):961\u2013968","journal-title":"Osteoporos Int"},{"issue":"4","key":"6012_CR44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10456-012-9285-x","volume":"15","author":"N Suffee","year":"2012","unstructured":"Suffee N et al (2012) RANTES\/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 15(4):727\u2013744","journal-title":"Angiogenesis"},{"issue":"48","key":"6012_CR45","doi-asserted-by":"publisher","first-page":"37895","DOI":"10.1074\/jbc.M110.129411","volume":"285","author":"I Berlin","year":"2010","unstructured":"Berlin I et al (2010) The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome*. J Biol Chem 285(48):37895\u201337908","journal-title":"J Biol Chem"},{"issue":"6","key":"6012_CR46","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1042\/BST20190527","volume":"47","author":"A Dufner","year":"2019","unstructured":"Dufner A, Knobeloch KP (2019) Ubiquitin-specific protease 8 (USP8\/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions. Biochem Soc Trans 47(6):1867\u20131879","journal-title":"Biochem Soc Trans"},{"key":"6012_CR47","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202306013","author":"A Endo","year":"2024","unstructured":"Endo A et al (2024) USP8 prevents aberrant NF-\u03baB and Nrf2 activation by counteracting ubiquitin signals from endosomes. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202306013","journal-title":"J Cell Biol"},{"issue":"9","key":"6012_CR48","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.4049\/jimmunol.1501496","volume":"196","author":"HY Yim","year":"2016","unstructured":"Yim HY et al (2016) Elevated response to type I IFN enhances RANKL-mediated osteoclastogenesis in Usp18-knockout mice. J Immunol 196(9):3887\u20133895","journal-title":"J Immunol"},{"issue":"8","key":"6012_CR49","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.7150\/ijbs.82152","volume":"19","author":"Z Feng","year":"2023","unstructured":"Feng Z et al (2023) The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ\/NFATC1 signalling. Int J Biol Sci 19(8):2319\u20132332","journal-title":"Int J Biol Sci"},{"issue":"5","key":"6012_CR50","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI34257","volume":"118","author":"W Jin","year":"2008","unstructured":"Jin W et al (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 118(5):1858\u20131866","journal-title":"J Clin Invest"},{"issue":"21","key":"6012_CR51","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201489729","volume":"33","author":"TM Durcan","year":"2014","unstructured":"Durcan TM et al (2014) USP8 regulates mitophagy by removing K6\u2010linked ubiquitin conjugates from parkin. EMBO J 33(21):2473\u20132491","journal-title":"EMBO J"},{"key":"6012_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1077058","volume":"14","author":"C Yan","year":"2023","unstructured":"Yan C et al (2023) Mitochondrial quality control and its role in osteoporosis. Front Endocrinol (Lausanne) 14:1077058","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"14","key":"6012_CR53","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.7150\/ijbs.46627","volume":"16","author":"S Wang","year":"2020","unstructured":"Wang S et al (2020) The role of autophagy and mitophagy in bone metabolic disorders. Int J Biol Sci 16(14):2675\u20132691","journal-title":"Int J Biol Sci"},{"issue":"1","key":"6012_CR54","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s41467-022-29401-6","volume":"13","author":"W Xiong","year":"2022","unstructured":"Xiong W et al (2022) Usp8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. Nat Commun 13(1):1700","journal-title":"Nat Commun"},{"issue":"4","key":"6012_CR55","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7(4):292\u2013304","journal-title":"Nat Rev Immunol"},{"key":"6012_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092073","author":"JM Kim","year":"2020","unstructured":"Kim JM et al (2020) Osteoblast-osteoclast communication and bone homeostasis. Cells. https:\/\/doi.org\/10.3390\/cells9092073","journal-title":"Cells"},{"key":"6012_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.818462","volume":"10","author":"N Zou","year":"2022","unstructured":"Zou N, Liu R, Li C (2022) Cathepsin K(+) non-osteoclast cells in the skeletal system: function, models, identity, and therapeutic implications. Front Cell Dev Biol 10:818462","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"6012_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/rvsc.2001.0522","volume":"72","author":"AW Gray","year":"2002","unstructured":"Gray AW, Davies ME, Jeffcott LB (2002) Localisation and activity of cathepsins K and B in equine osteoclasts. Res Vet Sci 72(2):95\u2013103","journal-title":"Res Vet Sci"},{"issue":"3","key":"6012_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.joca.2008.07.017","volume":"17","author":"T Vinardell","year":"2009","unstructured":"Vinardell T et al (2009) Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis. Osteoarthritis Cartilage 17(3):375\u2013383","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"6012_CR60","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0562","volume":"18","author":"Y Long","year":"2023","unstructured":"Long Y et al (2023) Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth. Open Life Sci 18(1):20220562","journal-title":"Open Life Sci"},{"issue":"13","key":"6012_CR61","doi-asserted-by":"publisher","first-page":"8914","DOI":"10.1021\/acs.jmedchem.2c00013","volume":"65","author":"Y Tian","year":"2022","unstructured":"Tian Y et al (2022) Discovery of potent small-molecule USP8 inhibitors for the treatment of breast cancer through regulating ER\u03b1 expression. J Med Chem 65(13):8914\u20138932","journal-title":"J Med Chem"},{"key":"6012_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116275","volume":"268","author":"Y Tian","year":"2024","unstructured":"Tian Y et al (2024) The discovery of potent USP2\/USP8 dual-target inhibitors for the treatment of breast cancer via structure guided optimization of ML364. Eur J Med Chem 268:116275","journal-title":"Eur J Med Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-06012-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:02:15Z","timestamp":1769965335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-06012-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6012"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-06012-0","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JHS is a scientific co-founder of AAVAA Therapeutics and AiTHEA Therapeutics and holds equity in the companies. Other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}